Cite
Effect of nitisinone (NTBC) treatment on the clinical course of hepatorenal tyrosinemia in Québec
MLA
Larochelle, Jean, et al. “Effect of Nitisinone (NTBC) Treatment on the Clinical Course of Hepatorenal Tyrosinemia in Québec.” Molecular Genetics & Metabolism, vol. 107, no. 1/2, Sept. 2012, pp. 49–54. EBSCOhost, https://doi.org/10.1016/j.ymgme.2012.05.022.
APA
Larochelle, J., Alvarez, F., Bussières, J.-F., Chevalier, I., Dallaire, L., Dubois, J., Faucher, F., Fenyves, D., Goodyer, P., Grenier, A., Holme, E., Laframboise, R., Lambert, M., Lindstedt, S., Maranda, B., Melançon, S., Merouani, A., Mitchell, J., Parizeault, G., & Pelletier, L. (2012). Effect of nitisinone (NTBC) treatment on the clinical course of hepatorenal tyrosinemia in Québec. Molecular Genetics & Metabolism, 107(1/2), 49–54. https://doi.org/10.1016/j.ymgme.2012.05.022
Chicago
Larochelle, Jean, Fernando Alvarez, Jean-François Bussières, Isabelle Chevalier, Louis Dallaire, Josée Dubois, Frédéric Faucher, et al. 2012. “Effect of Nitisinone (NTBC) Treatment on the Clinical Course of Hepatorenal Tyrosinemia in Québec.” Molecular Genetics & Metabolism 107 (1/2): 49–54. doi:10.1016/j.ymgme.2012.05.022.